A. Schultz et al., Interindividual heterogeneity in the hypoxic regulation of VEGF - Significance for the development of the coronary artery collateral circulation, CIRCULATION, 100(5), 1999, pp. 547-552
Citations number
34
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Background-The coronary artery collateral circulation may be beneficial in
protecting against myocardial ischemia and necrosis. However, there is a tr
emendous interindividual variability in the degree of new collateral format
ion in patients with coronary artery disease. The basis for this interindiv
idual heterogeneity is not understood. In this study we test the hypothesis
that failure to generate collateral vessels is associated with a failure t
o appropriately induce with hypoxia or ischemia the angiogenic factor, vasc
ular endothelial growth factor (VEGF).
Methods and Results-We correlated the VEGF response to hypoxia in the monoc
ytes harvested from patients with coronary artery disease with the presence
of collaterals visualized during routine angiography. We found that there
was a highly significant difference in the hypoxic induction of VEGF in pat
ients with no collaterals compared with patients with some collaterals (mea
n fold induction 1.9+/-0.2 versus 3.2+/-0.3, P < 0.0001). After subjecting
the data to ANCOVA, using as covariates a number of factors that might infl
uence the amount of collateral formation (ie, age, sex, diabetes, smoking,
hypercholesterolemia), patients with no collaterals still have a significan
tly lower hypoxic induction of VEGF than patients with collaterals.
Conclusions-This study provides evidence in support of the hypothesis that
the ability to respond to progressive coronary artery stenosis is strongly
associated with the ability to induce VEGF in response to hypoxia. The obse
rved interindividual heterogeneity in this response may be due to environme
ntal, epigenetic, or genetic causes. This interindividual heterogeneity may
also help to explain the variable angiogenic responses seen in other condi
tions such as diabetic retinopathy and solid tumors.